In vitro-Ishikawa cell test for assessing tissue-specific chemical effects on human endometrium

Reproductive Toxicology

Volumn 30, Issue 1, 2010, Pages 89-93

  Schaefer, W R ^a   Fischer, L ^a   Deppert, W R ^a   Hanjalic Beck, A ^a   Seebacher, L ^a   Weimer, M ^b   Zahradnik, H P ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Dose response relationship; Embryo implantation; Endometrium; Gene expression biomarker; Progesterone receptor; RT qPCR; Xenoestrogens

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; ENVIRONMENTAL CHEMICAL; ESTRADIOL; MESSENGER RNA; METHOXYACETIC ACID; NONYLPHENOL; PROGESTERONE RECEPTOR; ENDOCRINE DISRUPTOR;

ANALYTICAL ERROR; ARTICLE; ASSAY; CARCINOMA CELL; CHEMICAL ANALYSIS; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; GENE CONTROL; GENE TARGETING; HUMAN; HUMAN CELL; IN VITRO STUDY; ISHIKAWA CELL; QUANTITATIVE ANALYSIS; RECEPTOR UPREGULATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE SPECIFICITY; WESTERN BLOTTING; ANIMAL TESTING ALTERNATIVE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; ENDOMETRIUM; FEMALE; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; REPRODUCIBILITY; REPRODUCTION; STANDARDS; TOXICITY; TOXICITY TESTING; TUMOR CELL LINE;

ANIMAL TESTING ALTERNATIVES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ENDOMETRIUM; FEMALE; HUMANS; RECEPTORS, PROGESTERONE; REPRODUCIBILITY OF RESULTS; REPRODUCTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOXICITY TESTS; IN VITRO TECHNIQUES;

ANIMALIA;

EID: 77954082961     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2010.02.002     Document Type: Article

References (32)

1. Mendola P., Messer L.C., Rappazzo K. Science linking environmental contaminant exposures with fertility and reproductive health impacts in the adult female. Fertil Steril 2008, 89(Suppl. 1):e81-e94.
2. Caserta D., Maranghi L., Mantovani A., Marci R., Maranghi F., Moscarini M. Impact of endocrine disruptor chemicals in gynaecology. Hum Reprod Update 2008, 14:59-72.
3. Bremer S., Brittebo E., Dencker L., Gustafson A.L., Ehlert-Knudsen L., Mathisien L., et al. In vitro tests for detecting chemicals affecting the implantation process. Altern Lab Anim 2007, 35:421-439.
4. Sharkey A.M., Smith S.K. The endometrium as a cause of implantation failure. Best Pract Res Clin Obstet Gynaecol 2003, 17:289-307.
5. Strowitzki T., Germeyer A., Popovici R., Wolff M. The human endometrium as a fertility-determining factor. Hum Reprod Update 2006, 12:617-630.
6. Diedrich K., Fauser B.C.J.M., Devroey P., Griesinger G. The role of the endometrium and embryo in human implantation. Hum Reprod Update 2007, 13:365-377.
7. Norwitz E.R., Schust D.J., Fisher S.J. Implantation and the survival of early pregnancy. N Engl J Med 2001, 345:1400-1408.
8. Jabbour H.N., Kelly R.W., Fraser H.M., Critchley H.O.D. Endocrine regulation of menstruation. Endocr Rev 2006, 27:17-46.
9. Edwards R.G. Implantation, interception and contraception. Hum Reprod 1994, 9:985-995.
10. de Ziegler D., Romoscanu I., Ventura P., Ibecheole V., Fondop J.J., de Candolle G. The uterus and in vitro fertilization. Clin Obstet Gynecol 2006, 49:93-116.
11. Scippo M.L., Argiris C., van de Weerdt C., Muller M., Willemsen P., Martial J., et al. Recombinant human estrogen, androgen, and progesterone receptors for detection of potential endocrine disruptors. Anal Bioanal Chem 2004, 378:664-669.
12. Mirkin S., Archer D.F. Effects of mifepristone on vascular endothelial growth factor and thrombospondin-1 mRNA in Ishikawa cells: implication for the endometrial effects of mifepristone. Contraception 2004, 70:327-333.
13. Overk C.R., Yao P., Chadwick L.R., Nikolic D., Sun Y., Cuendet M.A., et al. Comparison of the in vitro estrogenic activities of compounds from Hops (Humulus lupulus) and Red Clover (Trifolium pratense). J Agric Food Chem 2005, 53:6246-6253.
14. Johnson S.M., Maleki-Dizaji M., Styles J.A., White I.N.H. Ishikawa cells exhibit differential gene expression profiles in response to oestradiol or 4-hydroxytamoxifen. Endocr Relat Cancer 2007, 14:337-350.
15. Ritz C, Streibig JC. Bioassay analysis using R.J Stat Soft 2005; 12: (Epub). http://www.jstatsoft.org/.
16. Boehme K., Simon S., Mueller S.O. Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol 2009, 236:85-96.
17. Naciff J.M., Khambatta Z.S., Thomason R.G., Carr G.J., Tiesman J.P., Singleton D.W., et al. The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci 2009, 107:40-55.
18. Ibarreta D., Daxenberger A., Meyer H.H.D. Possible health impact of phytoestrogens and xenoestrogens in food. APMIS 2001, 109:161-184.
19. Sonneveld E., Riteco J.A.C., Jansen H.J., Pieterse B., Brouwer A., Schoonen W.G., et al. Comparison of in vitro and in vivo screening models for androgenic and estrogenic activities. Toxicol Sci 2006, 89:173-187.
20. Bergeron J.M., Thompson T.B., Leonard L.S., Pluta L., Gaido K.W. Estrogenicity of bisphenol A in a human endometrial carcinoma cell line. Mol Cell Endocrinol 1999, 150:179-187.
21. Kumar N.S., Richer J., Owen G., Litman E., Horwitz K.B., Leslie K.K. Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Cancer Res 1998, 58:1860-1865.
22. Aoyama H., Couse J.F., Hewitt S.C., Haseman J.K., He H., Zheng X., et al. Upregulation of estrogen receptor expression in the uterus of ovarectomized B6C3F1 mice and Ishikawa cells treated with bromoethane. Toxicol Appl Pharmacol 2005, 209:226-235.
23. Henley D.V., Mueller S., Korach K.S. The short-chain fatty acid methoxyacetic acid disrupts endogenous estrogen receptor-α-mediated signaling. Environ Health Perspect 2009, 11:1702-1706.
24. Johnson M.D., Kenney N., Stoica A., Hilakivi-Clarke L., Singh B., Chepko G., et al. Cadmium mimics the in vivo effects of estrogen in the uterus and mammary gland. Nat Med 2003, 9:1081-1084.
25. Silva E., Lopez-Espinosa M.J., Molina-Molina J.M., Fernández M., Olea N., Kortenkamp A. Lack of activity of cadmium in in vitro estrogenicity assays. Toxicol Appl Pharmacol 2006, 216:20-28.
26. Krikun G., Mar G., Alvaro A., Guller S., Schatz F., Sapi E., et al. A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 2004, 145:2291-2296.
27. Lalitkumar P.G.L., Lalitkumar S., Meng C.X., Stavreus-Evers A., Hambiliki F., Bentin-Ley U., et al. Mifepristone, but not levonorgestrel, inhibits human blastocyst attachment to an in vitro endometrial three-dimensional cell culture model. Hum Reprod 2007, 22:3031-3037.
28. Teklenburg G., Macklon N.S. In vitro models for the study of early human embryo-endometrium interactions. Reprod Sci 2009, 16:811-818.
29. Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 2006, 6:360-368.
30. Shang Y., Brown M. Molecular determinants for the tissue specificity of SERMs. Science 2002, 295:2465-2468.
31. Klotz D.M., Arnold S.F., McLachlan J.A. Inhibition of 17 beta-estradiol and progesterone activity in human breast and endometrial cancer cells by carbamate insecticides. Life Sci 1997, 60:1467-1475.
32. Xu H., Kraus W.L., Shuler M.L. Development of a stable dual cell-line GFP expression system to study estrogenic endocrine disruptors. Biotechnol Bioeng 2008, 101:1276-1287.